MAPT and Alzheimer disease: Although pathological alterations of tau were thought to be downstream events of Aβ deposition, it is equally plausible that tau and Aβ act in parallel to enhancing each other's toxic effects and initiate the pathogenic events germane to AD (Small and Duff, 2008; Spires-Jones and Hyman, 2014; Bennett et al., 2017).